Dupont D - Search Results

1

Improving Performance of Clinical Research: Development and Interest of Electronic Health Records.

Beresniak A, Schmidt A, Dupont D, Sundgren M, Kalra D, De Moor GJ. Beresniak A, et al. Among authors: dupont d. Biomed Res Int. 2015;2015:864549. doi: 10.1155/2015/864549. Epub 2015 Oct 12. Biomed Res Int. 2015. PMID: 26543872 Free PMC article. No abstract available.

2

e-Health standardization in Europe: lessons learned.

De Moor GJ, Claerhout B, van Maele G, Dupont D. De Moor GJ, et al. Among authors: dupont d. Stud Health Technol Inform. 2004;100:233-7. Stud Health Technol Inform. 2004. PMID: 15718584

3

Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis.

Russell A, Beresniak A, Bessette L, Haraoui B, Rahman P, Thorne C, Maclean R, Dupont D. Russell A, et al. Among authors: dupont d. Clin Rheumatol. 2009 Apr;28(4):403-12. doi: 10.1007/s10067-008-1060-4. Epub 2008 Dec 17. Clin Rheumatol. 2009. PMID: 19089488

4

Direct cost-modeling of rheumatoid arthritis according to disease activity categories in France.

Beresniak A, Gossec L, Goupille P, Saraux A, Bamberger M, Bregman B, Dupont D. Beresniak A, et al. Among authors: dupont d. J Rheumatol. 2011 Mar;38(3):439-45. doi: 10.3899/jrheum.100589. Epub 2010 Dec 1. J Rheumatol. 2011. PMID: 21123324

5

Modelling cost-effectiveness of biologic treatments based on disease activity scores for the management of rheumatoid arthritis in Spain.

Beresniak A, Ariza-Ariza R, Garcia-Llorente JF, Ramirez-Arellano A, Dupont D. Beresniak A, et al. Among authors: dupont d. Int J Inflam. 2011;2011:727634. doi: 10.4061/2011/727634. Epub 2011 Jun 28. Int J Inflam. 2011. PMID: 21785694 Free PMC article.

6

A Bayesian network approach to the study of historical epidemiological databases: modelling meningitis outbreaks in the Niger.

Beresniak A, Bertherat E, Perea W, Soga G, Souley R, Dupont D, Hugonnet S. Beresniak A, et al. Among authors: dupont d. Bull World Health Organ. 2012 Jun 1;90(6):412-417A. doi: 10.2471/BLT.11.086009. Epub 2012 Jan 20. Bull World Health Organ. 2012. PMID: 22690030 Free PMC article.

7

Interest of modelling in rheumatoid arthritis.

Beresniak A, Dupont DM, Becker JC, Merkesdal S. Beresniak A, et al. Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S96-101. Epub 2012 Oct 18. Clin Exp Rheumatol. 2012. PMID: 23078913 Review.

8

Cost-effectiveness simulation model of biologic strategies for treating to target rheumatoid arthritis in Germany.

Beresniak A, Baerwald C, Zeidler H, Krüger K, Neubauer AS, Dupont D, Merkesdal S. Beresniak A, et al. Among authors: dupont d. Clin Exp Rheumatol. 2013 May-Jun;31(3):400-8. Epub 2013 Mar 4. Clin Exp Rheumatol. 2013. PMID: 23464803

9

Electronic health records: new opportunities for clinical research.

Coorevits P, Sundgren M, Klein GO, Bahr A, Claerhout B, Daniel C, Dugas M, Dupont D, Schmidt A, Singleton P, De Moor G, Kalra D. Coorevits P, et al. Among authors: dupont d. J Intern Med. 2013 Dec;274(6):547-60. doi: 10.1111/joim.12119. Epub 2013 Oct 18. J Intern Med. 2013. PMID: 23952476 Free article. Review.

10

Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.

Beresniak A, Medina-Lara A, Auray JP, De Wever A, Praet JC, Tarricone R, Torbica A, Dupont D, Lamure M, Duru G. Beresniak A, et al. Among authors: dupont d. Pharmacoeconomics. 2015 Jan;33(1):61-9. doi: 10.1007/s40273-014-0216-0. Pharmacoeconomics. 2015. PMID: 25230587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters